The noradrenergic system and its involvement in aggressive behaviors

Aggression and Violent Behavior

Volumn 12, Issue 1, 2007, Pages 1-15

  Haden, Sara Chiara ^a   Scarpa, Angela ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

Aggression; Neurochemicals; Norepinephrine

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; CLONIDINE; CLOZAPINE; NORADRENALIN; PROPRANOLOL;

AGGRESSION; AGONIST; CATABOLISM; HUMAN; MODEL; NEUROCHEMISTRY; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; RESEARCH; REVIEW; STRESS; SYNTHESIS; VIOLENCE;

EID: 33845602506     PISSN: 13591789     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.avb.2006.01.012     Document Type: Review

References (77)

1. Anderson C.A., and Bushman B.J. External validity of "trivial" experiments: The case of laboratory aggression. Review of General Psychology 1 1 (1997) 19-41
2. Bailly D. The role of β-adrenoceptor blockers in the treatment of psychiatric disorders. CNS Drugs 5 2 (1996) 115-136
3. Bank L., Duncan T., Patterson G.R., and Reid J. Parent and teacher ratings in the assessment and prediction of antisocial and delinquent behavior. Journal of Personality 61 (1993) 693-709
4. Beneditti F., Sforsini L., Colombo C., Maffei C., and Smeraldi E. Low-dose clozapine in acute and continuation treatment of severe borderline personality disorder. Journal of Clinical Psychiatry 59 3 (1998) 103-107
5. Berman M.E., and Coccaro E.F. Neurobiologic correlates of violence: Relevance to criminal responsibility. Behavioral Sciences and the Law 16 (1998) 303-318
6. Berridge C.W., and Waterhouse B.D. The locus coeruleus-noradrenergic system: Modulation of behavioral state and state-dependent cognitive processes. Brain Research Reviews 42 (2003) 33-84
7. Brower M.C., and Price B.H. Neuropsychiatry of frontal lobe dysfunction in violent and criminal behaviour: A critical review. Journal of Neurology, Neurosurgery, and Psychiatry 71 (2001) 720-726
8. Brown C.S., and Cooke S.C. Attention deficit hyperactivity disorder: Clinical features and treatment options. CNS Drugs 1 2 (1994) 95-106
9. Brown G.L., Ebert M.H., Goyer P.F., Jimerson D.C., Klein W.J., Bunney W.E., and Goodwin F.K. Aggression, suicide, and serotonin: Relationships to CSF amine metabolites. American Journal of Psychiatry 139 6 (1982) 741-746
10. Brown G.L., Goodwin F.K., Ballenger J.C., and Goyer P.F. Cerebrospinal fluid amine metabolites and cyclin nucleotides in human aggression. Psychopharmacology Bulletin 17 1 (1981) 63-65
11. Buzan R.D., Dubovsky S.L., Firestone D., and Dal Pozzo E. Use of clozapine in 10 mentally retarded adults. Journal of Neuropsychiatry and Clinical Neurosciences 10 (1998) 93-95
12. Cai B., Matsumoto K., Ohta H., and Watanabe H. Biphasic effects of typical antidepressants and mianserin, an atypical antidepressant, on aggressive behavior in socially isolated mice. Pharmacology, Biochemistry, and Behavior 44 (1993) 519-525
13. Carlson N.R. Physiology of behavior (2001), Allyn And Bacon, Massachusetts
14. Casey D.E. The relationship of pharmacology to side effects. Journal of Clinical Psychiatry 58 10 (1997) 55-62
15. Cherek D.R. Effects of smoking different doses of nicotine on human aggressive behavior. Psychopharmacology 75 (1981) 339-345
16. Citrome L., and Volavka J. Management of violence in schizophrenia. Psychiatric Annals 30 1 (2000) 41-52
17. Coccaro E.F., and Kavoussi R.J. Neurotransmitter correlates of impulsive aggression. In: Stoff D.M., and Carins R.B. (Eds). Aggression and Violence: Genetic, Neurobiological, and Biosocial Perspectives (1996), Lawrence Erlbaum Associates, Inc, New Jersey 67-85
18. 2A receptors gene (ADRA2A) and measures of irritability, hostility, impulsivity and memory in normal subjects. Psychiatric Genetics 10 (2000) 39-42
19. Cunningham J.G. Textbook of veterinary physiology (2002), W.B. Saunders Company, Pennsylvania
20. Demaree H.A., Higgins D.A., Williamson J., and Harrison D.W. Asymmetry in hand grip strength and fatigue in low-and high-hostile men. International Journal of Neuroscience 112 4 (2002) 415-428
21. Deutch A.Y., and Roth R.H. Neurotransmitters. In: Zigmond M.J., Bloom F.E., Landis S.C., Roberts J.L., and Squire L.R. (Eds). Fundamental Neuroscience (1999), Academic Press, San Diego, California 193-234
22. Eichelman B.S., and Barchas J. Facilitated shock-induced aggression following antidepressive medication in the rat. Pharmacology, Biochemistry, and Behavior 3 4 (1975) 601-604
23. Gerra G., Zaimovic A., Ampollini R., Giusti F., Delsignore R., Raggid M.A., et al. Experimentally induced aggressive behavior in subjects with 3,4-methylenedioxy-methamphetamine ("ecstasy") use history: Psychobiological correlates. Journal of Substance Abuse 13 (2001) 471-491
24. Gerra G., Zaimovic A., Avanzini P., Chittolini B., Giucastro G., Caccavari R., et al. Neurotransmitter-neuroendocrine responses to experimentally induced aggression in humans: Influence of personality variable. Psychiatry Research 66 (1997) 33-43
25. Gerra G., Zaimovic A., Sartori R., Raggi M.A., Bocchi C., Zambelli U., et al. Experimentally induced aggressiveness in adult children of alcoholics (ACOAs): Preliminary behavioral and neuroendocrine findings. Journal of Studies on Alcohol 60 (1999) 776-783
26. 3-adrenoceptor: An update. European Journal of Endocrinology 132 (1995) 377-385
27. Glazer W.M., and Dickson R.A. Clozapine reduces violence and persistent aggression in schizophrenia. Journal of Clinical Psychiatry 59 3 (1998) 8-14
28. Greendyke R.M., Kanter D.R., Schuster D.B., Verstreate S., and Wooton J. Propranolol treatment of assaultive patients with organic brain disease: A double-blind crossover, placebo-controlled study. Journal of Nervous and Mental Disorders 174 (1984) 290-294
29. Greendyke R.M., Schuster D.B., and Wooton J. Propranolol treatment of assaultive patients with organic brain disease. Journal of Clinical Psychopharmacology 4 5 (1986) 282-285
30. In: Guralnik D.B. (Ed). Webster's new word dictionary. (6th ed.). (1984), Warner Communications Company, New York
31. Hahn R.A., Hynes M.D., and Fuller R.W. Apomorphine-induced aggression in rats chronically treated with oral clonidine: Modulation by central serotonergic mechanisms. Journal of Pharmacology and Experimental Therapeutics 220 2 (1982) 389-393
32. Haller J., and Barna I. Hormonal and metabolic responses during psychosocial stimulation in aggressive and nonaggressive rats. Psychoneuroendocrinology 20 (1995) 65-74
33. Haller J., Makara G.B., and Kruk M.R. Catecholaminergic involvement in the control of aggression: Hormones, the peripheral sympathetic, and central noradrenergic systems. Neuroscience and Biobehavioral Reviews 22 1 (1998) 85-97
34. Haugh R.M., and Markesbery W.R. Hypothalamic astrocytoma: Syndrome of hyperaphagia, obesity, and disturbances of behavior and endocrine and automatic function. Archives of Neurology 40 (1983) 560-563
35. Hegstrand L.R., and Eichelman B. Increased shock-induced fighting with supersensitive β-adrenergic receptors. Pharmacology, Biochemistry, and Behavior 19 (1983) 313-320
36. Higley J.D., Suomi S.J., and Linnoila M. A longitudinal assessment of CSF monoamine metabolite and plasma cortisol concentrations in young rhesus monkeys. Biological Psychiatry 32 (1992) 127-145
37. Hollander E., Posner N., and Cherkasky S. Neuropsychiatric aspects of aggression and impulse control disorders. In: Yudofsky S.C., and Hales R.E. (Eds). Neuropsychiatry and Clinical Neurosciences. 4th ed. (2002), American Psychiatric Publishing, Washington, D.C 579-596
38. Kandel E.R. Transmitter release. In: Kandel E.R., Schwartz J.H., and Jessell T.M. (Eds). Principles of neural science. 3rd ed. (1991), Appleton And Lange, Norwalk, Connecticut 194-212
39. Kandel E.R., Siegelbaum S.A., and Schwartz J.H. Elementary interactions between neurons: Synaptic transmission. In: Kandel E.R., Sdchwartz J.H., and Jessell T.M. (Eds). Principles of Neural Science. 3rd ed. (1991), Appleton And Lange, Norwalk, Connecticut 120-134
40. Kavoussi R., Armstead P., and Coccaro E. The neurobiology of impulsive aggression. The Psychiatric Clinics of North America 20 2 (1997) 395-403
41. Korzan W.J., Summers T.R., Ronan P.J., Renner K.J., and Summers C.H. The role of monoaminergic nuclei during aggression and sympathetic social signaling. Brain, Behavior, and Evolution 57 (2001) 317-327
42. Korzan W.J., Summers T.R., and Summers C.H. Monoaminergic activities of limbic systems are elevated during aggression: Influence of synaptic social signaling. Brain Research 870 (2000) 170-178
43. Koshes R.J., and Rock N.L. Use of clonidine for behavioral control in an adult patient with autism. American Journal of Psychiatry 151 11 (1994) 1714
44. Lamprecht F., Eichelman B.S., Thoa N.B., Williams R.B., and Kopin I.J. Rat fighting behavior: Serum dopamine-β-hydroxylase and hypothalamic tyrosine hydroxylase. Science 177 (1972) 1214-1221
45. Levine E.S., Litto W.J., and Jacobs B.L. Activity of cat locus coeruleus noradrenergic neurons during the defense reaction. Brain Research 531 (1990) 189-195
46. Lewis D.O., Pincus J.H., Feldman M., Jackson L., and Bard B. Psychiatric, neurological, and psychoeducational characteristics of 15 death row inmates in the United States. American Journal of Psychiatry 143 7 (1986) 838-845
47. Mason S.T. Catecholamines and behaviour (1984), Cambridge University Press, Oxford, England
48. Matsumoto K., Cai B., Satoh T., Ohta H., and Watanabe H. Desipramine enhances isolation-induced aggressive behavior in mice. Pharmacology, Biochemistry, and Behavior 39 (1991) 167-170
49. Michals M.L., Crismon M.L., Roberts S., and Childs A. Clozapine response and adverse effects in nine brain-injured patients. Journal of Clinical Psychopharmacology 13 3 (1993) 198-203
50. Miller N.E. Chemical coding of behavior in the brain. Science 148 (1965) 328-338
51. Minneman K.P. Adrenergic receptor molecules. In: Yamamura H.I., and Enna S.J. (Eds). Neurotransmitter Receptors: Part 2 Biogenic Amines (1981), Chapman And Hall, London 185-268
52. Morpurgo C. Aggressive behavior induced by large doses of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride in mice. European Journal of Pharmacology 3 (1968) 374-377
53. Ozawa H., Miyauchi T., and Sugawari K. Potentiating effects of lithium chloride on aggressive behavior induced in mice by nialamide plus L-DOPA and by clonidine. European Journal of Pharmacology 34 (1975) 169-179
54. Placidi G.P.A., Oquendo M.A., Malone K.M., Huang Y., Ellis S.P., and Mann J.J. Aggressivity, suicide attempts, and depression: Relationship to cerebrospinal fluid monoamine metabolite levels. Biological Psychiatry 50 (2001) 783-791
55. Raine A. The psychopathology of crime (1993), Academic Press, Inc, London
56. Raine A., Brennan P., and Farrington D.P. Biosocial bases of violence: Conceptual and theoretical issues. In: Raine A., Brennan P.A., Farrington D.P., and Mednick S.A. (Eds). Biosocial Bases of Violence (1997), Plenum Press, New York
57. Ratey J.J., Mikkelsen E.J., and Smith G.B. Beta-blockers in the severely and profoundly mentally retarded. Journal of Clinical Psychopharmacology 6 (1986) 103-107
58. Reuster T., Rilke O., and Oehler J. High correlation between salivary MHPG and CSF MHPG. Psychopharmacology 164 4 (2002) 415-418
59. Saver J.L., Salloway S.P., Devinsky O., and Bear D.M. Neuropsychiatry of aggression. In: Fogel B.S., Schiffer R.B., and Rao S.M. (Eds). Neuropsychiatry (1996), Williams And Wilkins, Baltimore, Md 523-548
60. Silver J.M., and Yudofsky S.C. Aggressive disorders. In: Silver J.M., Yudofsky S.C., and Hales R.E. (Eds). Neuropsychiatry of Traumatic Brain Injury (1994), American Psychiatric Press, Inc, Washington, D.C. 313-356
61. Silver J.M., Yudofsky S.C., Slater J.A., Gold R.K., Stryer B.L.K., Williams D.T., et al. Propranolol treatment of chronically hospitalized aggressive patients. Journal of Neuropsychiatry and Clinical Neurosciences 11 (1999) 328-335
62. Sorgi P.J., Ratey J.J., and Polakoff S. â-Adrenergic blockers for the control of aggressive behaviors in patients with chronic schizophrenia. American Journal of Psychiatry 143 (1986) 775-776
63. Southwick S.M., Krystal J.H., Morgan A., Johnson D., Nagy L.M., Nicolaou A., et al. Abnormal noradrenergic function in posttraumatic stress disorder. Archives of General Psychiatry 50 (1993) 266-274
64. Stanford S.C. Noradrenaline. In: Webster R.A. (Ed). Neurotransmitters, Drugs, and Brain Function (2001), Wiley And Sons, Ltd, London 163-186
65. Tanaka T., Yoshida M., Yokoo H., Tomita M., and Tanaka M. Expression of aggression attenuates both stress-induced gastric ulcer formation and increases in noradrenaline release in the rat amygdala assessed by intracerebral microdialysis. Pharmacology, Biochemistry, and Behavior 59 1 (1998) 27-31
66. Tedeschi J.T., and Quigley B.M. A further comment on the construct validity of laboratory aggression paradigms: A response to Giancola and Chermack. Aggression and Violent Behavior 5 2 (2000) 127-136
67. Thoa N., Eichelman B., Richardson B., and Jacobwitz D. 6-Hydroxydopa depletion of brain norepinephrine and the facilitation of aggressive behavior. Science 178 (1972) 75-77
68. Tsuda A., Tanaka M., Ida Y., Shirao I., Gondoh Y., Oguchi M., et al. Expression of aggression attenuates stress-induced increases in rat brain noradrenaline turnover. Brain Research 474 (1988) 174-180
69. Valzelli L. Reflections on experimental and human pathology of aggression. Progress in Neuropsychopharmacology and Biological Psychiatry 8 3 (1984) 311-325
70. Virkkunen M., Dejong J., Bartko J., Goodwin F.K., and Linnoila M. Relationship of psychological variables to recidivism in violent offenders and impulsive fire setters: A follow-up study. Archives of General Psychiatry 46 (1989) 600-603
71. Virkkunen M., Eggert M., Rawlings R., and Linnoila M. A prospective follow-up study of alcoholic violent offenders and fire setters. Archives of General Psychiatry 53 (1996) 523-529
72. Volavka J. Genetic and neurochemical correlates of violence. Psychiatric Annals 27 10 (1997) 679-682
73. Volavka J. The neurobiology of violence: An update. Journal of Neuropsychiatry and Clinical Neuroscience 11 3 (1999) 307-314
74. Volavka J. Neurobiology of violence. 2nd ed. (2002), American Psychiatric Press, Washington D.C.
75. Webster R.A. Neurotransmitters, drugs and brain function (2001), John Wiley And Sons, LTD, Chichester, UK
76. Yudofsky S.C., Stevens L., Silver J., Barsa J., and Williams D. Propranolol in the treatment of rage and violent behavior associated with Korsakoff's psychosis. American Journal of Psychiatry 141 1 (1984) 114-115
77. Yudofsky S., Williams D., and Gorman J. Propranolol in the treatment of rage and violent behavior in patients with chronic brain syndrome. American Journal of Psychiatry 138 2 (1981) 218-220